Literature DB >> 1092715

Utilization of cultured human lymphoid cells for detection of humoral sensitization in prospective recipients of kidney transplants.

S Ferrone, A Ting, M A Pellegrino, P I Terasaki, R A Reisfeld.   

Abstract

Prospective recipients of kidney transplants were tested for lymphocytotoxicity; from these we selected 102 sera that lacked cytotoxic antibodies against peripheral lymphocytes from at least 80 unrelated subjects. To detect humoral sensitization, we then reacted these with 17 cultured human lymphoid cell lines having different HL-A phenotypes. Cytotoxic antibodies reacting with these cultured cells were now detected in some of the sera. These antibodies were not directed against HL-A antigens, yet mediated lysis of target cells in the presence of rabbit but not of human or guinea pig complement. Furthermore, they activated the classical pathway of the rabbit complement system. Later, a significant association was found between occurrence of cytotoxic antibodies and rejection of the transplant. Thus, cultured human lymphoid cells, because of their great susceptibility to complement-mediated lysis, appear to be useful in detecting humoral sensitization in candidates for kidney grafts.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092715      PMCID: PMC301757          DOI: 10.1172/JCI107942

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.

Authors:  B Hampar; J G Derge; L M Martos; J L Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

2.  Activation of human complement by human lymphoid cells sensitized with histocompatibility alloantisera.

Authors:  S Ferrone; N R Cooper; M A Pellegrino; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

3.  Use of lymphoblastoid cell-lines to determine responsiveness in cadaveric renal transplantation.

Authors:  P J Morris; L J Dumble
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

4.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

5.  Stability of HL-A and appearance of other antigens (LIVA) at the surface of lymphoblasts grown in vitro.

Authors:  D Bernoco; P R Glade; S Broder; V C Miggiano; K Hirschhorn; R Ceppellini
Journal:  Haematologica       Date:  1969       Impact factor: 9.941

6.  Anomalies in HL-A typing.

Authors:  H M Dick; C M Steel
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

7.  Lymphocyte-typing changes after short-term culture.

Authors:  P Mackintosh; D A Hardy; T Aviet
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

8.  Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids.

Authors:  I Berggård; A G Bearn
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

9.  The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.

Authors:  A L Sandberg; A G Osler; H S Shin; B Oliveira
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

Review 10.  Expression of histocompatibility antigens during the growth cycle of cultured lymphoid cells.

Authors:  S Ferrone; M A Pellegrino; M P Dierich; R A Reisfeld
Journal:  Curr Top Microbiol Immunol       Date:  1974       Impact factor: 4.291

View more
  4 in total

1.  Cross-reactivity between human and murine lymphocyte antigens. IV. Reactivity of H-2 alloantisera with HLA-A, B antigens.

Authors:  V Quaranta; M A Pellegrino; G N Callahan; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

2.  Ultrastructural alterations in human lymphoblastoid B cell lines treated with tunicamycin.

Authors:  M C Glassy; S Ferrone
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

3.  The monoclonal xenoantibody Q6/64 recognizes a determinant expressed by certain gene products of the A and B loci of the HLA region.

Authors:  V Quaranta; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA.

Authors:  K A Thomas; N M Valenzuela; D Gjertson; A Mulder; M C Fishbein; G C Parry; S Panicker; E F Reed
Journal:  Am J Transplant       Date:  2015-04-22       Impact factor: 8.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.